previous reference ID: 56 next reference

CandActCFTR used public reference

The following publication reference has been reported to contain CFTR related structural information.
"H Yang" "B Yu" "X Gao" "L Zhu" "Y Zhang" "L Chen" "T Ma"


Below you will find all the structures identified in the publication. Be warned that this does not imply any activity. n=5

ID: 12
InChIKey: WMBWREPUVVBILR-WIYYLYMNSA-N
SMILES: C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O

biological descriptors:

CFTR relevance: CFTR activator

Category:
Influence on CFTR function enhances CFTR function
Order of interaction indirect
subcellular compartment several

chemical graph of compound 12



CID is 65064
synonyms found at PubChem are:
(-)-Epigallocatechin gallate, EGCG, Epigallocatechin gallate, 989-51-5, Epigallocatechin 3-gallate, Epigallocatechin-3-gallate, Tea catechin, (-)-Epigallocatechin-3-o-gallate, Teavigo, (-)-Epigallocatechol gallate, Epigallocatechin-3-monogallate, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate, Catechin deriv., UNII-BQM438CTEL, Green tea extract, CCRIS 3729, (-)-epigallocatechin 3-gallate, C22H18O11, BQM438CTEL, CHEBI:4806, CHEMBL297453, (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, WMBWREPUVVBILR-WIYYLYMNSA-N, Epigallocatechol, 3-gallate, (-)-, (-)-Epigallocatechin gallate (EGCG), [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, DSSTox_CID_567, DSSTox_RID_78830, DSSTox_GSID_29889, Sunphenon, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate, EGCG cpd, (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate), (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate), CAS-989-51-5, SMR000449288, epigallo-catechin gallate, SR-01000759328, L-Epigallocatechin gallate, PF-EGCg 90, Epigallocate, NVP-XAA 723, (-)-EGCG, Epigallocic acid, Teavigo;, EGCG analogs, GTPs,Anagen, 2kdh, 3oob, 4awm, EGCG, Anagen, KDH, Epigallocatcchin Gallate, Spectrum_000316, SpecPlus_000277, Spectrum2_000168, Spectrum3_000244, Spectrum4_001541, Spectrum5_000102, Galloyl-L-epigallocatechol, D0E9DB, D0U2BH, AC1L22IG, AC1Q5X0Z, (-)-Epigallocatechin gallat, (-)-Epigallocatehin gallate, SCHEMBL35258, BSPBio_001628, KBioGR_002002, KBioSS_000796, SPECTRUM210239, cid_65064, EPIGALOCATECHIN GALLATE, MLS000758300, MLS001424000, DivK1c_006373, Green tea polyphenols, Anagen, SPBio_000035, Epigallocatechin gallate(EGCG), Epigallocatechin monogallate, B, GTPL7002, MEGxp0_001166, Epigallocatechin gallate, Anagen, DTXSID1029889, ACon1_001054, KBio1_001317, KBio2_000796, KBio2_003364, KBio2_005932, KBio3_001128, AOB2839, (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, EGCG solution, 20 mM in DMSO, MolPort-001-741-358, (-)-EpigallocatechinGallateHydrate, HMS2051K21, HMS3649E08, ZINC3870412, Tox21_201468, Tox21_303457, BDBM50070942, CCG-38378, FR-109, LMPK12030005, MFCD00075940, s2250, AKOS015918182, ACN-035233, CS-1258, DB12116, DS-9030, EBD2138593, LS-2197, MCULE-3341525983, MCULE-7760530136, NC00078, SDCCGMLS-0066550.P001, (-)-Epigallocatechin gallate, >=95%, Epigallocatechin gallate analogs, Anagen, KS-0000132O, NCGC00164319-01, NCGC00164319-02, NCGC00164319-03, NCGC00164319-04, NCGC00164319-06, NCGC00257243-01, NCGC00259019-01, AN-15867, BP-30205, CPD000449288, HY-13653, K791, SAM001247031, SC-47284, ST097428, AB0014381, KB-206444, E0694, FT-0082796, FT-0604392, N1874, C09731, W-5069, (-)-Epigallocatechin gallate, >=97.0% (HPLC), (-)-Epigallocatechin gallate, analytical standard, 989E515, Epigallocatechin Gallate solution, 20 mM in DMSO, Gallic acid, 3-ester with epigallocatechol, (-)-, SR-01000946601, epigallocatechin-3-gallate solution, 20 mM in DMSO, I14-7747, Q-100914, SR-01000759328-5, SR-01000759328-6, SR-01000946601-1, (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT), (-)-Epigallocatechin Gallate solution, 20 mM in DMSO, (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate, ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE, UNII-T432289GYZ component WMBWREPUVVBILR-WIYYLYMNSA-N, (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea, (-)-Epigallocatechin Gallate, disposable screening library format, Epigallocatechin gallate, primary pharmaceutical reference standard, (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard, (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate, [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate, Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material, (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate, (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate, 863-65-0, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-, Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester

ID: 61
InChIKey: PFTAWBLQPZVEMU-DZGCQCFKSA-N
SMILES: C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O

biological descriptors:

CFTR relevance: no effect

Category:
Influence on CFTR function none
Order of interaction unknown
subcellular compartment unknown

chemical graph of compound 61



CID is 9064
synonyms found at PubChem are:
(+)-catechin, CATECHIN, Cianidanol, 154-23-4, Catechuic acid, Cyanidanol, Catechinic acid, D-Catechin, Catergen, Cianidol, (+)-Cyanidanol, (+)-Catechol, (+)-Cyanidan-3-ol, Biocatechin, D-(+)-Catechin, Catechin (flavan), Catechol (flavan), Dexcyanidanol, D-Catechol, (+)-Catechin Hydrate, (2R,3S)-Catechin, 3-Cyanidanol, (+)-, (2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol, Cianidanolum, Catechu, Gambier, Transepar, Katha, (+)-Cyanidanol-3, (2R,3S)-(+)-Catechin, (+)-Cianidanol, Cutch (dye), 3,3',4',5,7-Flavanpentol, KB-53, CCRIS 6855, (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol, Cianidanol [INN:JAN], C.I. Natural Brown 3, Cianidanolum [INN-Latin], NSC 2819, UNII-8R1V1STN48, Catechol (+), 2,3-trans-catechin, 2,3-Dihydro-4-desoxoquercetin, CHEBI:15600, AI3-22757, NSC2819, (+)-(2R,3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol, CATECHIN, D, (2R,3S)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-, EINECS 205-825-1, Catechin-(+,-) hydrate, 7295-85-4, (2R,3S)-3,3',4',5,7-Flavanpentol, 8R1V1STN48, CHEMBL311498, PFTAWBLQPZVEMU-DZGCQCFKSA-N, NSC-2819, (2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 2H-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3S)-, C15H14O6, trans-(+)-3,3',4',5,7-Flavanpentol, Zyma, Cyanidanol-3, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, (+)-Cyanidol-3, (+)-(2R:3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol, (3S,2R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, (+/-)-Catechin hydrate, Epicatechin-(-), dl-Catechol, (-)-Catechol, MLS001056745, Catechine dl-form, (+/-)-Catechin, 321-01-7, (+-)-catechin, KB 53, SR-01000075742, SMR000326724, Catechinate, Catechuate, Ent-Catechin, Z 7300, Procyanidin polymer, Teafuran 30A, KXN, Prestwick_998, Sunkatol No. 1, EINECS 230-731-2, (+)-catechinhydrate, Spectrum_000395, (+)-Catechin,(S), 2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol #, Prestwick0_000642, Prestwick0_000817, Prestwick1_000642, Prestwick1_000817, Prestwick2_000642, Prestwick2_000817, Prestwick3_000642, Spectrum2_000167, Spectrum3_000242, Spectrum4_001763, Spectrum5_000345, Epitope ID:116872, AC1L1S8M, Lopac0_000219, SCHEMBL19741, BSPBio_000643, BSPBio_001624, KBioGR_002245, KBioSS_000875, BIDD:ER0378, DivK1c_000647, ( )-2-(3,4-Dihydroxyphenyl)-3,5,7-chromantriol, (+)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromantriol, (-)-trans-3,3',4',5,7-Pentahydroxyflavane, SPBio_000033, SPBio_002564, SPBio_002634, BPBio1_000709, cid_107957, DTXSID3022322, ACon1_001489, BDBM23416, BDBM60836, HMS502A09, KBio1_000647, KBio2_000875, KBio2_003443, KBio2_006011, KBio3_001124, KS-00000ZEC, 3,3',4',5,7 Cflavanpentol, YK-85 Light Yellow Powder 85, 4c94, MolPort-001-740-277, NINDS_000647, HMS1570A05, HMS1570D15, HMS2097A05, HMS3260L19, Pharmakon1600-00210205, ZINC119983, (+)-Catechin, analytical standard, HY-N0898, TNP00270, Tox21_500219, 6282AF, ANW-46737, CCG-40007, LMPK12020001, NSC755824, s4722, Cianidanol solution, 20 mM in DMSO, trans3,3,4,5,7 pentahydroxyflavane, AKOS015960546, trans-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, CS-3759, LP00219, MCULE-1532117250, ND-0342, NSC-755824, SDCCGMLS-0066526.P001, IDI1_000647, NCGC00017331-01, NCGC00017331-02, NCGC00017331-03, NCGC00017331-04, NCGC00017331-05, NCGC00093689-01, NCGC00093689-02, NCGC00093689-03, NCGC00260904-01, (+)-Catechin solution, 20 mM in DMSO, 100786-01-4, AC-11608, AJ-11643, AN-44045, BC202817, LS-39923, LS-53711, NCI60_002303, SC-46023, ST057176, ZB004048, SBI-0050207.P003, AX8035583, ST2407915, TC-135482, EU-0100219, FT-0613995, ST24039239, (-)-trans-3,3',4',5,7-Pentahydroxyflavan, (2S,3R)-3,3',4',5,7-Pentahydroxyflavane, C 1251, C06562, Cianidanol, disposable screening library format, AB00051886_13, 154C234, A809512, NATURAL BROWN 3 (CUTCH EXTRA OR GAMBIER), Q-100183, SR-01000075742-1, SR-01000075742-7, SR-01000075742-8, SR-01000075742-9, BRD-K58736316-001-07-9, BRD-K58736316-001-08-7, SR-01000075742-10, SR-01000075742-12, SR-01000075742-14, D4A04A57-7609-451F-A446-53F4DFAD15F5, UNII-5J4Y243W61 component PFTAWBLQPZVEMU-DZGCQCFKSA-N, (2R,3S)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol;hydrate, (+)-Catechin, United States Pharmacopeia (USP) Reference Standard, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-1H-chromene-3,5,7-triol, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;hydrate, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol;hydrate, (2R,3S)-2-[3,4-bis(oxidanyl)phenyl]-3,4-dihydro-2H-chromene-3,5,7-triol, (2R,3S)-2-[3,4-bis(oxidanyl)phenyl]-3,4-dihydro-2H-chromene-3,5,7-triol;hydrate, (2R-trans)-2-(3,4-Dihydroxyphenyl)-3-4-dihydro-2H-1-benzopyran-3,5,7-triol, 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (2R-trans), 2H-1-Benzopyran-3,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-, 2H-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3S)-, 159761-73-6, 16198-00-8, 29907-20-8, 4211-28-3, 5323-80-8, 72690-97-2, InChI=1/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s

ID: 1309
InChIKey: LSHVYAFMTMFKBA-TZIWHRDSSA-N
SMILES: C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O

biological descriptors:

CFTR relevance: CFTR activator

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

chemical graph of compound 1309



CID is 107905
synonyms found at PubChem are:
(-)-Epicatechin gallate, 1257-08-5, Epicatechin gallate, (-)-Epicatechin-3-O-gallate, L-Epicatechin gallate, (-)-Epicatechin-3-gallate, (-)-epicatechingallate, epicatechin monogallate, (-)-Epicatechin 3-O-gallate, Teatannin, Epicatechol, gallate, UNII-92587OVD8Z, 3-O-Galloylepicatechin, 3-Gallate(-)-Epicatechol, epicatechin gallate, (2R-cis)-isomer, NSC 636594, (-)-cis-3,3',4',5,7-Pentahydroxyflavane 3-gallate, CHEMBL36327, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, ECG, CHEBI:70255, LSHVYAFMTMFKBA-TZIWHRDSSA-N, 92587OVD8Z, C22H18O10, epicatechin-3-O-gallate, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-cis)-, (-)-cis-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, epi-Catechin 3-O-gallate, Epicatechol, gallate (6CI), NSC636594, (-)epicatechingallate, Epicatechin 3-gallate, Spectrum_000314, SpecPlus_000275, (-) epicatechin gallate, Spectrum2_000165, Spectrum3_000246, Spectrum4_001540, Spectrum5_000080, epicatechin gallate (ECG), (-)-Epicatechin gallate,, AC1L32YN, 3-Galloyl-(-)-epicatechin, SCHEMBL39047, BSPBio_001632, KBioGR_001980, KBioSS_000794, SPECTRUM210238, (-)-Epicatechin-3-gallate,, DivK1c_006371, SPBio_000029, AC1Q5X10, MEGxp0_000810, (-)-epi-Catechin 3-O-gallate, (-)-Epicatechin-3-O-gallate,, CTK8E0233, Epicatechol, 3-gallate, (-)-, KBio1_001315, KBio2_000794, KBio2_003362, KBio2_005930, KBio3_001132, 3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, MolPort-001-740-964, HY-N0002, ZINC3978503, BDBM50153015, CCG-38376, CE0014, LMPK12020090, MFCD00075936, AKOS015965216, AC-6037, AM84365, CS-3761, MCULE-8110076741, SDCCGMLS-0066549.P001, 3-Galloyl-(2R,3R)-(-)-Epicatechin, Epicatechol, 3-gallate, (-)- (8CI), NCGC00179135-01, AJ-47571, AN-48941, AS-15722, LS-38401, Q429, AB0017581, AX8001457, KB-277863, E0890, ST24033389, 257E085, C-22380, SR-05000002675, Q-200002, SR-05000002675-1, BRD-K50660797-001-01-0, BRD-K50660797-001-03-6, (-)-Epicatechin gallate, >=98% (HPLC), from green tea, UNII-T432289GYZ component LSHVYAFMTMFKBA-TZIWHRDSSA-N, Epicatechin gallate, primary pharmaceutical reference standard, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl] 3,4,5-trihydroxybenzoate, (-)-cis-3,3 inverted exclamation marka,4 inverted exclamation marka,5,7-Pentahydroxyflavane 3-gallate, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2R,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, 3,4,5-Trihydroxybenzoic Acid (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl Ester, Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7- dihydroxy-2H-1-benzopyran-3-yl ester, (-)-cis-

ID: 1686
InChIKey: PFTAWBLQPZVEMU-UKRRQHHQSA-N
SMILES: C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O

biological descriptors:

CFTR relevance: no effect

Category:
Influence on CFTR function none
Order of interaction unknown
subcellular compartment unknown

chemical graph of compound 1686



CID is 72276
synonyms found at PubChem are:
(-)-Epicatechin, 490-46-0, Epicatechin, L-Epicatechin, (-)-Epicatechol, l-Acacatechin, (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol, Epicatechol, l-Epicatechol, (-)epicatechin, (2R,3R)-(-)-Epicatechin, UNII-34PHS7TU43, epi-Catechin, epi-Catechol, CCRIS 7097, EINECS 207-710-1, NSC 81161, CHEBI:90, Epicatechol, (-)-, 34PHS7TU43, PFTAWBLQPZVEMU-UKRRQHHQSA-N, (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol, C15H14O6, 2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene, (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-, DSSTox_CID_25133, DSSTox_RID_80694, DSSTox_GSID_45133, d-Epicatechin, (2R,3R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, (+)-epicatechol, Epicatechin-(-), (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, CAS-490-46-0, SMR000156230, (.+-.)-Epicatechol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-, (+/-)-Catechin hydrate, alpha-catechin, NSC81161, Catechin C, .alpha. Catechin, Epicatechin (EC), NCGC00015215-02, 28E, 7295-85-4, L(-)-Epicatechin, Prestwick_203, 2,3-cis-epicatechin, PubChem6021, (2S,3S)-3,3',4',5,7-pentahydroxyflavan, (-)-cis-Epicatechin, L-Epicatechin ,(S), Spectrum_000159, SpecPlus_000267, AC1L2HRG, AC1Q7ABQ, Spectrum2_000675, Spectrum3_000243, Spectrum4_000949, Spectrum5_000929, Lopac-C-1251, Oprea1_209947, SCHEMBL19412, BSPBio_001626, KBioGR_001538, KBioSS_000639, SPECTRUM210206, cid_72276, MLS001304012, MLS001304152, DivK1c_006363, SPBio_000769, (2S,3S)-(+)-Epicatechin, CHEMBL583912, DTXSID4045133, ACon1_001106, BCBcMAP01_000224, BDBM23417, CTK8C4815, KBio1_001307, KBio2_000639, KBio2_003207, KBio2_005775, KBio3_001126, KS-00000YHE, MolPort-001-740-232, HMS1923M05, KUC104404N, ZINC119988, 17334-50-8, HY-N0001, KS-000004ZL, Tox21_110101, 3,3',4',5,7-Pentahydroxyflavane, ANW-73226, CCG-38571, LMPK12020003, s4723, (-)-Epicatechin, analytical standard, AKOS015895981, Tox21_110101_1, (-)-Epicatechin, >=90% (HPLC), ACN-035300, CS-3760, DB12039, DS-3358, EBD2184991, KSC-10-144, MCULE-8775451204, SDCCGMLS-0066927.P001, SMP1_000115, NCGC00015215-01, NCGC00016415-01, NCGC00016415-02, NCGC00016415-03, NCGC00016415-04, NCGC00017331-08, AC-14586, AJ-11648, AK105372, BP-30203, CAS-154-23-4, LS-63981, P692, ZB004050, CAS-7295-85-4, AX8020996, KB-206384, ST2402222, TR-031372, (+)-cis-3,3',4',5,7-Pentahydroxyflavan, B4964, FT-0614024, C09727, 490E460, (-)-Epicatechin, >=98% (HPLC), from green tea, I06-1232, Q-200001, CF3BA0C2-DE1B-44AB-A4D3-800F017221BA, Epicatechin, primary pharmaceutical reference standard, UNII-T432289GYZ component PFTAWBLQPZVEMU-UKRRQHHQSA-N, (2S-cis)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-Benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R,3R)-, 2545-08-6, 863644-80-8, 863644-83-1

ID: 2610
InChIKey: XMOCLSLCDHWDHP-UHFFFAOYSA-N
SMILES: C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O

biological descriptors:

CFTR relevance: no effect

Category:
Influence on CFTR function none
Order of interaction unknown
subcellular compartment unknown

chemical graph of compound 2610



CID is 1249
synonyms found at PubChem are:
CHEBI:71224, 2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (-)EPIGALLOCATECHIN, NSC674038, NSC674039, (-)-3,5,7,3',4',5'-Hexahydroxylflavan, AC1L1B1Z, AC1Q79WI, CHEMBL404845, SCHEMBL1972940, CTK8D5887, (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, 13425-13-3, AKOS032947774, flavan-3,3',4',5,5',7-hexol, 3,3',4',5,5',7-Hexahydroxyflavan, 3,5,7,3',4',5'-Hexahydroxyflavan, NCGC00095541-01, 4CH-024112, 2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman, CCD3AC6F-06C0-43D8-94C8-58130D45DFA9, 2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-